Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal

SIMPLE SUMMARY: Proton pump inhibitors (PPIs) are prescribed for reducing the amount of stomach acid. PPIs increase the systemic level of gastrin, a trophic hormone, which is reported to be linked with carcinogenesis. Previous epidemiological studies have shown that the use of PPIs increase the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Poly, Tahmina Nasrin, Lin, Ming-Chin, Syed-Abdul, Shabbir, Huang, Chih-Wei, Yang, Hsuan-Chia, Li, Yu-Chuan (Jack)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264794/
https://www.ncbi.nlm.nih.gov/pubmed/35804824
http://dx.doi.org/10.3390/cancers14133052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264794/
https://www.ncbi.nlm.nih.gov/pubmed/35804824
http://dx.doi.org/10.3390/cancers14133052

Ejemplares similares